Skip to Content

ILSR Welcomes the FTC’s Lawsuit Against Drug Middlemen and Urges Further Action

  • Sep 24, 2024
  • Press Release
  • Independent Business
  • Antimonopoly
  • Antitrust
  • Health Care
  • PBMS
  • Pharmacies
  • Economic Justice